Materialise NV

MTLS
$5.69 -0.06 (-1.04%)
🚫 Materialise NV does not pay dividends

Company News

Surgical Simulation Market Research Report 2025-2030
GlobeNewswire Inc. • Researchandmarkets.Com • November 11, 2025

The global surgical simulation market is projected to grow at a 15.65% CAGR from 2024 to 2030, reaching $1.14 billion, driven by technological advancements in VR, AI, and haptic feedback that enhance medical training and reduce surgical errors.

Global 3D Printing Medical Devices Market to Evolve at a Phenomenal 17.1% CAGR through 2031 | SkyQuest Technology
Benzinga • Globe Newswire • October 16, 2024

The global 3D printing medical devices market is projected to grow at a CAGR of 17.1% from 2024 to 2031, driven by advancements in 3D printing technologies and rising demand for personalized healthcare solutions.

Stratasys (SSYS) Tests 3D Printed Models in Orthopedic Oncology
Zacks Investment Research • Zacks Equity Research • June 27, 2024

Stratasys (SSYS) and Ricoh co-sponsor a clinical study comparing the efficacy of 3D-printed models to traditional CT or MRI scanning for bone tumor excision planning.

Why Materialise Stock Was Falling on Tuesday
The Motley Fool • [email protected] (John Ballard) • February 14, 2023

Investors are looking for balance of top- and bottom-line growth in this environment.

Tracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2022 Update
Seeking Alpha • John Vincent • October 19, 2022

ARK Invest’s 13F portfolio value decreased from $16.91B to $14.35B this quarter. Click to see the firm's trades for Q3 2022.

Related Companies